Cargando…

Limited Evolution of Inferred HIV-1 Tropism while Viremia Is Undetectable during Standard HAART Therapy

BACKGROUND: HIV patients on suppressive antiretroviral therapy have undetectable viremia making it impossible to screen plasma HIV tropism if regimen change is required during suppression. We investigated the prevalence and predictors of tropism switch from CCR5-using (“R5”) to non-CCR5-using (“non-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Guinevere Q., Dong, Winnie, Mo, Theresa, Knapp, David J. H. F., Brumme, Chanson J., Woods, Conan K., Kanters, Steve, Yip, Benita, Harrigan, P. Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048224/ https://www.ncbi.nlm.nih.gov/pubmed/24905411 http://dx.doi.org/10.1371/journal.pone.0099000

Ejemplares similares

Immunodominant Anti-Gag SLYNTVATL Responses in HIV-patients With More Than Five Years of HAART-induced Undetectable Plasma Viremia
por: Remenar, Anica, et al.
Publicado: (2005)

Short-term variation of HIV tropism readouts in the absence of CCR5 antagonists
por: Brumme, CJ, et al.
Publicado: (2010)

Theoretical and experimental assessment of degenerate primer tagging in ultra-deep applications of next-generation sequencing
por: Liang, Richard H., et al.
Publicado: (2014)

Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAART
por: Hogg, Robert S, et al.
Publicado: (2006)

What happens to cardiovascular system behind the undetectable level of HIV viremia?
por: d’Ettorre, Gabriella, et al.
Publicado: (2016)

Validation of a Genotype-Independent Hepatitis C Virus Near-Whole Genome Sequencing Assay
por: Lapointe, Hope R., et al.
Publicado: (2021)

Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay
por: Brumme, Chanson J., et al.
Publicado: (2012)

Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia
por: Garrido, C, et al.
Publicado: (2010)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viremia
por: Višković, Klaudija, et al.
Publicado: (2018)

Calibration and accuracy of the geno2pheno co-receptor algorithm for predicting HIV tropism for single and triplicate measurements of V3 genotype
por: Swenson, LC, et al.
Publicado: (2010)

Phylogenetic Dependency Networks: Inferring Patterns of CTL Escape and Codon Covariation in HIV-1 Gag
por: Carlson, Jonathan M., et al.
Publicado: (2008)

Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes
por: Cashin, Kieran, et al.
Publicado: (2015)

HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy
por: Shahid, Aniqa, et al.
Publicado: (2022)

Prevalence and Risk Factors Associated to Chronic Kidney Disease in HIV-Infected Patients on HAART and Undetectable Viral Load in Brazil
por: Menezes, Andréia M., et al.
Publicado: (2011)

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
por: DUNCAN, Maggie C., et al.
Publicado: (2023)

HIV-1 tropism in low-level viral load HIV-1 infections during HAART in Guangdong, China
por: Zhang, Chuyu, et al.
Publicado: (2023)

“Dynamic Range” of Inferred Phenotypic HIV Drug Resistance Values in Clinical Practice
por: Swenson, Luke C., et al.
Publicado: (2011)

HIV-1 Tropism Testing in Subjects Achieving Undetectable HIV-1 RNA: Diagnostic Accuracy, Viral Evolution and Compartmentalization
por: Pou, Christian, et al.
Publicado: (2013)

Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome
por: Pasternak, Alexander O., et al.
Publicado: (2009)

Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control
por: Bartha, István, et al.
Publicado: (2017)

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada
por: Rocheleau, Genevieve, et al.
Publicado: (2017)

Absence of seroreversion in 80 HAART-treated HIV-1 seropositive patients with at least five-years undetectable plasma HIV-1 viral load
por: Cornelissen, Marion, et al.
Publicado: (2006)

Direct non-productive HIV-1 infection in a T-cell line is driven by cellular activation state and NFκB
por: Dahabieh, Matthew S, et al.
Publicado: (2014)

Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification
por: Lima, Viviane D., et al.
Publicado: (2017)

Residual Viremia in an RT-SHIV Rhesus Macaque HAART Model Marked by the Presence of a Predominant Plasma Clone and a Lack of Viral Evolution
por: Kauffman, Robert C., et al.
Publicado: (2014)

Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
por: Montaner, Julio S.G., et al.
Publicado: (2014)

Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy
por: Alves, Brunna M., et al.
Publicado: (2017)

Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs
por: Montoya, Vincent, et al.
Publicado: (2021)

Nephrotoxicity of HAART
por: Kalyesubula, Robert, et al.
Publicado: (2011)

Trends in human papillomavirus (HPV) infection among HIV-positive women in the pre-HAART and HAART era in a Nigerian clinic
por: Onigbogi, MO, et al.
Publicado: (2010)

Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
por: Lima, Viviane D, et al.
Publicado: (2014)

Inferring the proportion of undetected cholera infections from serological and clinical surveillance in an immunologically naive population
por: Finger, Flavio, et al.
Publicado: (2023)

Bocavirus viremia
por: Sukkaromdee, Pathoom, et al.
Publicado: (2015)

Correction: Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1
por: Brumme, Zabrina L, et al.
Publicado: (2007)

Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1
por: Brumme, Zabrina L, et al.
Publicado: (2007)

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis
por: Kamelian, Kimia, et al.
Publicado: (2019)

Neurodegeneration in the HAART era
por: Brew, Bruce J
Publicado: (2010)

“Deep” Sequencing Accuracy and Reproducibility Using Roche/454 Technology for Inferring Co-Receptor Usage in HIV-1
por: Knapp, David J. H. F., et al.
Publicado: (2014)

Mechanisms of Foot-and-Mouth Disease Virus Tropism Inferred from Differential Tissue Gene Expression
por: Zhu, James J., et al.
Publicado: (2013)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
por: Hoffman, Risa M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qpgbpol5a8bk1ij43rb2jfbhtt